Forward Together: Locking in Team Culture
Duke Clinical Research Institute builds a lasting tradition around celebrating milestone moments
Study Confirms No Benefit to Taking Ivermectin for COVID-19 Symptoms
Ivermectin is one of three repurposed medications tested in ACTIV-6, a nationwide double-blind study
Trial finds common malaria prevention regimen reduces complications of sickle cell anemia in Kenyan children
A study by the Duke Clinical Research Institute comparing three treatment methods of preventing malaria in children with sickle cell anemia (SCA) found one method reduces common complications of th
Duke STAR Program trains next generation of research professionals
The latest cohort of young researchers got a head start on learning the skills necessary to build a future in research over the summer, as they completed the Duke STAR program in August, 2022.
DCRI Highlights from AHA Scientific Sessions
Faculty, Fellows Share the Latest Innovative, Impactful Cardiovascular Research
Largest Randomized Trial Evaluates Steroids for Infant Heart Surgery
Less complex heart patients may benefit, but not without risk
Chest Pain Patients Benefit from Precision Diagnostic Testing Approach
Comparative Study of Two Heart Failure Drugs Finds No Difference in Outcomes
Study offers clarity after one of the diuretics had been perceived as more effective
Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the